Latest News and Press Releases

Amsterdam, The Netherlands - 09 November 2018 Esperite announces that the preparation of its Annual Report 2017 is nearly finalized and expects the publication of its Annual Report 2017 before...

Amsterdam, the Netherlands - 7 November 2018 Esperite's (Euronext: ESP) biotech company The Cell Factory has obtained the patent for the use of extracellular vesicles (EVs) in the treatment of...

Amsterdam, the Netherlands - 6 November 2018 The Cell Factory in collaboration with the University of Padova, Italy has completed pre-clinical in-vivo tests of the CF-MEV-132 drug candidate for...

Amsterdam, The Netherlands - 15 October 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a 22nd  Tranche of EUR 400,000 is issued as a private placement of 40...

Amsterdam, The Netherlands - 3 October 2018 Esperite N.V. (Euronext: ESP, the "Company" or "Esperite") today announced that the sale agreement between Esperite and Go-Life Healthcare Limited...

CryoSave has fully equipped this new safe and secure sample storage BioBank in its state-of-the-art central laboratory in Geneva, Switzerland especially designed for optimal cryopreservation of...

Amsterdam, The Netherlands - 31 August 2018 Esperite NV announced mid-August that the Company had solved the technical issues that caused the delay regarding the publication of the Annual Report...

Amsterdam, The Netherlands - 29 August 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a 21st Tranche of EUR 300,000 is issued as a private placement of 30...

Amsterdam, The Netherlands - 15 August 2018 Esperite NV announces having solved the technical issues that caused the delay regarding the publication of the Annual Report 2017. The departments...

Amsterdam, The Netherlands - 18 July 2018 Following earlier information provided regarding the delay on the publication of the Annual Report 2017 mainly due to technical issues which have now...